Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Amniotic membrane products can be a valuable tool to aid in the treatment of a variety of corneal diseases and can be added to other treatments to help patients find relief. Two ophthalmologists discussed the different types of products available and best applications.
➤ FDA grants IDE for synthetic endothelial layer study ➤ NDA submission for wet AMD treatment advances ➤ Positive feedback moves forward NDA submission plans ➤ Company news ➤ ASCRS news and events
It was a successful year for the Journal of Cataract & Refractive Surgery (JCRS), the official journal of ASCRS and ESCRS, and JCRS Online Case Reports (JCRO), an online-only companion journal to JCRS. To celebrate this success, EyeWorld is featuring some of the most-viewed papers.
➤ FDA approves treatment for macular edema following RVO ➤ New cyclosporine product receives approval for dry eye ➤ First human implant of 3D-bioprinted cornea ➤ Topline results from Phase 3 trial for Stargardt disease ➤ First patient treated with IDE glaucoma therapy ➤ Enrollment complete for Phase 2 trial for geographic atrophy treatment ➤ First patient implanted with investigational glaucoma shunt in trial ➤ Positive review of Phase 3 pivotal trial for AMD ➤ Company news ➤ ASCRS news and events
Ophthalmologists, particularly corneal specialists, may encounter a variety of pathogens that can cause infectious keratitis. Two of these specialists went into detail on some of the infections, including those that may be considered “atypical,” and how to identify and diagnose them.
A pair of recent studies from the Diabetes Endothelial Keratoplasty Study Group published in JAMA Ophthalmology found that diabetes status did not affect success of DMEK outcomes overall, nor did it result in greater endothelial cell loss when compared to tissue from a donor without diabetes.
➤ Complete response letter issued for low-dose atropine drop ➤ Extension study shows reduced GA growth with intravitreal treatment ➤ Durable, 3-year vision improvements seen with optogenetic therapy ➤ Preclinical data supports long-acting nature of investigational anti-VEGF for wet AMD ➤ Company news ➤ ASCRS news and events
➤ FDA approves epithelium-on crosslinking treatment ➤ 12-month results from Phase 1/2 trial evaluating regenerative cell therapy for corneal endothelial disease ➤ Phase 3 data supports nonsteroidal treatment for uveitic macular edema ➤ FDA approves IDE for glaucoma device ➤ Company news ➤ ASCRS news and events
The ocular surface impacts many ophthalmic subspecialties beyond cornea. Whether it’s within refractive surgery, cataract surgery, glaucoma therapy, or retina procedures, the ocular surface can affect outcomes for patients being treated by these subspecialists. Several anterior segment ophthalmologists spoke about the ocular surface and how it relates to their subspecialty.
➤ Insulin-based treatment for neurotropic keratitis advances ➤ Study evaluating implantable telescope in patients with late-stage AMD begins ➤ Registrational trial to begin for investigational neuroprotective therapy ➤ Enrollment complete in pivotal trials for wet AMD treatment ➤ ASCRS news and events